Top 10 — Financials — 1 Sep 2026

Valuation 97th (price to book 0.8, price to earnings 5.7) and capital return 89th (net share count bought back over the year 4.8); weakest is profitability (79th, return on equity 23.4%, operating margin 29.1%).

• Profitability78.5
• Growth85.3
• Financial health86.9
• Valuation96.8
• Capital return89.1
• Trend81.3

Profitability 95th (operating margin 53.1%, return on equity 50.7%) and financial health 93rd (free cash flow margin 74.5%, debt to equity 0); weakest is capital return (19th, net share count bought back over the year -8.9).

• Profitability94.5
• Growth92.5
• Financial health92.8
• Valuation81.0
• Capital return19.1
• Trend85.2

Growth 85th (revenue growth year over year 28.2%) and capital return 84th (net share count bought back over the year 4.6, consecutive years of dividend increases 5 years); weakest is trend (74th, a "golden cross" — its 50-day average is above its 200-day).

• Profitability75.1
• Growth84.7
• Financial health83.5
• Valuation80.2
• Capital return83.8
• Trend74.2

Financial health 90th (free cash flow margin 46.3%, debt to equity 0.1) and profitability 90th (operating margin 48.6%, return on equity 32.6%); weakest is capital return (49th, net share count bought back over the year -1.5, consecutive years of dividend increases 4 years).

• Profitability90.1
• Growth81.1
• Financial health90.2
• Valuation79.0
• Capital return48.7
• Trend63.1

Growth 90th (3-year revenue CAGR 29.8%, revenue growth year over year 34.9%) and capital return 86th (net share count bought back over the year 5.6, consecutive years of dividend increases 5 years); weakest is trend (68th, a strong downtrend, with sellers in control).

• Profitability69.7
• Growth90.1
• Financial health73.3
• Valuation74.3
• Capital return86.2
• Trend67.9

Capital return 99th (net share count bought back over the year 28.2) and valuation 92nd (price to earnings 6, price to book 1.2); weakest is financial health (51st, free cash flow margin 8.1%, debt to equity 0.3).

• Profitability72.6
• Growth73.7
• Financial health50.8
• Valuation91.7
• Capital return99.4
• Trend75.7

Financial health 95th (debt to equity 0) and profitability 81st (operating margin 40.5%, return on equity 20.7%); weakest is trend (64th, a strong downtrend, with sellers in control).

• Profitability81.1
• Growth64.2
• Financial health94.5
• Valuation77.0
• Capital return80.2
• Trend63.8

Growth 86th (revenue growth year over year 51.5%, 3-year revenue CAGR 15.2%) and trend 84th (a strong uptrend, with buyers in control); weakest is valuation (48th, price to earnings 15.9, price to book 2.9).

• Profitability80.4
• Growth85.7
• Financial health77.4
• Valuation48.0
• Capital return63.7
• Trend84.3

Growth 93rd (revenue growth year over year 43.2%) and profitability 74th (operating margin 44.6%, return on equity 13.4%); weakest is trend (65th, a trend forming but not yet strong (ADX below 25)).

• Profitability73.7
• Growth93.0
• Financial health73.6
• Valuation71.5
• Capital return68.9
• Trend65.0

Growth 92nd (revenue growth year over year 39.4%) and valuation 86th (price to book 0.9, price to earnings 10.6); weakest is capital return (41st, net share count bought back over the year -45.3, consecutive years of dividend increases 5 years).

• Profitability62.1
• Growth91.9
• Financial health82.5
• Valuation86.4
• Capital return40.8
• Trend61.4